Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Biocytogen Launches New Division to Partner Antibodies and License Mice Platforms

publication date: Jan 24, 2024

Biocytogen Pharma (Beijing) launched a new sub-brand, RenBiologics™, that will be in charge of its antibody discovery business division. RenBiologics will be responsible for out-licensing and co-development of the company’s library of fully human antibodies, as well as licensing RenMice®, the company’s fully human antibody/TCR discovery platforms. Based on gene editing technology, Biocytogen uses its genetically engineered proprietary RenMice® platforms to discover fully human monoclonal/bispecific/multispecific antibodies, bispecific antibody-drug conjugates, nanobodies and TCR-mimic antibodies. Biocytogen regularly announces agreements with biopharmas for its products, though it does not disclose any financial figures. More details....

Stock Symbol: (HK: 02315)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital